Persistent low-grade inflammation in the brain has been reported to exacerbate neurodegenerative pathologies, including PD and Alzheimer diseases, with pro-inflammatory cytokines such as IL-1β and IL-6 considered key drivers [29–33]. This evidence concerns the gene IL1B and Parkinson disease.